Final Program

SUNDAY • MAY 15 59
P1220
P1221
P1222
P1223
P1224
P1225
P1226
P1227
P1228
Facilitator:
P1229
P1230
P1231
Clinical Features and Predictive Factors for Long-Term
Follow-Up in Polymyositis/Dermatomyositis-Associated
Interstitial Lung Diseases/T. Fujisawa, H. Hozumi, M. Kono, N.
Enomoto, Y. Nakamura, N. Inui, R. Nakashima, Y. Imura, T.
Mimori, T. Suda, Hamamatsu, Japan, p.A1537
Anti-Aminoacyl-tRNA Synthetase Antibodies in Patients with
Nonspecific Interstitial Pneumonia Diagnosed by Surgical
Lung Biopsy/M. Yamasue, M. Ando, H. Matsumoto, H. Yoshikawa,
S. Toba, K. Umeki, J. Kadota, Yufu, Japan, p.A1538
Mycophenolate Mofetil (MMF) as Initial Treatment in
Antisynthetase Syndrome - A Case Report/J.M. Intaphan, A.
Selvaggio, Los Angeles, CA, p.A1539
Retrospective Analysis of Twelve Patients with
Anti-Synthetase Syndrome - Mayo Clinic Experience/K. Linga,
S.W. Robison, A. Lee, I. Mira-Avendano, Jacksonville, FL, p.A1540
Interstitial Lung Disease and Myositis-Specific and Associated
Autoantibodies: Patients Have Similar Clinical Manifestations
Although a Heterogeneous Serologic Profile and Prognosis/J.
Rojas Serrano, D.I. Perez-Roman, D. Herrera-Bringas, P.
Castorena-Garcia, M. Mejia, H. Mateos-Toledo, J. Castillo-Pedroza,
A. Estrada, R. Guevara, Mexico City, Mexico, p.A1541
Clinical Characteristics of 27 Patients with Interstitial
Pneumonia Associated with Anti-Aminoacyl-tRNA-Synthetase
Antibodies/S. Izumi, A. Shiozawa, H. Kawamoto, S. Ishii, M.
Suzuki, E. Morino, J. Takasaki, G. Naka, T. Sato, M. Iikura, Y.
Takeda, M. Hojo, H. Sugiyama, Tokyo, Japan, p.A1542
Serum Cytokine Profiles of Anti-CADM-140/MDA5 Positive
Patients with Amyopathic Dermatomyositis and Rapidly
Progressive Interstitial Lung Disease/T. Takada, A. Aoki, K.
Asakawa, T. Sakagami, H. Moriyama, T. Kikuchi, S. Sato,
Minami-uonuma, Japan, p.A1543
Prognostic Factors in Dermatomyositis-Associated Rapidly
Progressive Interstitial Pneumonias Treated by Direct
Hemoperfusion Using Polymyxin B-Immobilized Fiber
Column/H. Okabayashi, H. Ichiyasu, S. Hirooka, K. Kojima, T.
Jodai, Y. Sakamoto, H. Ideguchi, S. Hamada, C. Yoshida, S.
Hirosako, S. Okamoto, H. Kohrogi, Kumamoto city, Japan, p.A1544
Interstitial Pneumonia with Autoimmune Features (IPAF)
Presenting with Acute Respiratory Failure and Critical Illness:
A Case Series/G. Grasselli, B. Vergnano, M.R. Pozzi, V.L. Sala, A.
Pesci, A. Pesenti, Milano, Italy, p.A1545
K.E. Black, MD, Boston, MA
Differences in Lung Abnormalities Between Primary and
Secondary Sjogren’s Syndrome/N. Kobayashi, H. Koizumi, K.
Takahashi, A. Ihata, S. Nagaoka, T. Kaneko, Yokohama, Japan,
p.A1546
Diffuse Alveolar Hemorrhage Secondary to ANCA-Associated
Vasculitis: Role of Plasma Exchange and Induction of
Remission Therapy/R. Cartin-Ceba, L.A. Diaz-Caballero, M.O.
Al-Qadi, S. Tryfon, F.C. Fervenza, S.R. Ytterberg, U. Specks,
Scottsdale, AZ, p.A1547
Pulmonary Risk Factors for Lung Cancer in Systemic
Sclerosis: A Single Center Case-Control Study/K. Secunda, J.
Katzen, R. Agrawal, J. Patel, M. Hinchcliff, A. Rademaker, J.E.
Dematte, Chicago, IL, p.A1548
P1232
P1233
P1234
P1235
P1236
P1237
P1238
A43
Effect of Diastolic Dysfunction on Six Minute Walk Test
Performance in Patients With Scleroderma/A. Gadre, C.
Ghattas, O.A. Minai, K.B. Highland, Cleveland, OH, p.A1549
Differential Expression of Proteins in Scleroderma Patients
with and Without Interstitial Lung Disease/J.S. Lee, R. Keith, C.
Meadows, A. Fischer, T.M. Bull, Aurora, CO, p.A1550
HLA- Genotyping and Clinical Manifestation in Patients with
Granulomatosis with Polyangiitis/M.S. Tavares, L.K. Dourado, J.
Pinaffi, E.P. Oliveira, H. Rodrigues, C.S.V. Barbas, Sao Paulo,
Brazil, p.A1551
The Importance of the Systemic Sclerosis Phenotype and the
New Criteria for Interstitial Pneumonia with Autoimmune
Features in the Prognosis of Patients Affected by Interstitial
Lung Disease/H. Mateos-Toledo, L. Quintana-Arroyo, J.
Rojas-Serrano, D. Perez-Roman, A. Garrido, J. Castillo-Pedroza,
M. Mejia, Mexico City, Mexico, p.A1552
Physiologic Variance of Serial DLCO in Scleroderma Lung
Disease/A. Flora, Toledo, OH, p.A1553
An Analysis of Prognostic Factors in Patients with Interstitial
Pneumonia with Autoimmune Features/Y. Ito, T. Ishida, M. Arita,
H. Yoshioka, M. Noyama, F. Tokioka, A. Ito, H. Yokoyama, T.
Kaneda, R. Takei, S. Kumagai, Kurashiki okayama, Japan, p.A1554
Hepatic Steatosis Accompanies Pulmonary Alveolar
Proteinosis/A.N. Hunt, A. Malur, T. Montfort, S. Mahajan, A.D.
Postle, M.J. Thomassen, Southampton, United Kingdom, p.A1555
THEMATIC POSTER SESSION
ALPHA-1-ANTITRYPSIN DEFICIENCY
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
R.A. Sandhaus, MD, PhD, Littleton, CO
P1240 Cardiovascular Risk and Lung Disease Severity in Alpha 1
Antitrypsin Deficiency/D. Griffiths, C.E. Bolton, P. Nightingale,
R.A. Stockley, E. Sapey, Birmingham, United Kingdom, p.A1556
P1241
P1242
Prevalence and Nature of Liver Involvement in Patients with
PiZZ-Emphysema, Candidates for Lung Transplantation/H. Mal,
L. Morer, L. Choudat, G. Dauriat, F. Durand, D. Cazals-Hatem, G.
Thabut, O. Brugiere, Paris, France, p.A1557
The Effect of Alpha-1 Proteinase Inhibitor (A1-PI) Therapy on
Changes in Regional Lung Density: A Post-Hoc Analysis of the
RAPID Trial/D. Parr, N.G. McElvaney, K.R. Chapman, J. Burdon,
N. Seersholm, J.M. Stocks, R.A. Sandhaus, O. Vit, M. Fries, J.M.
Edelman, Coventry, United Kingdom, p.A1558
SUNDAY MORNING
ATS 2016 • San Francisco